A 5488

New Jersey Assembly Bill
2022-2023 Regular Session

Introduced in Assembly May 18, 2023
Assembly
Senate
Governor

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

View Latest Bill Text

Sign In to Follow

Bill Subjects

Drug Abuse

Abstract

Bill Sponsors (1)

Kevin J. Rooney

Republican

Votes

No votes to display

Actions

May 18, 2023

Assembly

Introduced in the Assembly, Referred to Assembly Judiciary Committee

Bill Text

Bill Text Versions	Format
Introduced Version	PDF HTML

Related Documents

Document	Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New Jersey Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.